2 months ago
NBIX
AnalystsDavid AmsellemDavid Amsellem's Stock Forecasts
AnalystsDavid Amsellem
Analyst Ranking
Top 7%
#353 out of 5020 analysts
Average Return
+15.11%
Win Rate
61%71 out of 117
Risk vs Reward
Poor
Good
David Amsellem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amneal Pharmaceuticals IncAMRX | +222.28% | $2.02 | $6.51 | 2023-05-08 - 2024-05-07 | Strong Buy |
Indivior PLCINDV | +207.91% | $7.46 | $22.97 | 2024-10-11 - 2025-09-17 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +189.77% | $31.56 | $91.45 | 2020-04-14 - 2021-04-14 | Strong Buy |
Indivior PLCINDV | +155.22% | $9.00 | $22.97 | 2024-10-25 - 2025-09-17 | Strong Buy |
Indivior PLCINDV | +134.44% | $9.90 | $23.21 | 2024-09-13 - 2025-09-12 | Strong Buy |
David Amsellem Analyst Color
Get additional color on David Amsellem's coverage of popular stocks
5 months ago
CORT
7 months ago
CORT
8 months ago
TEVA
10 months ago
AMRX
a year ago
INDV
a year ago
CORT
a year ago
NBIX
a year ago
CORT
a year ago
AMRX
a year ago
JAZZ
2 years ago
IRWD
2 years ago
TEVA
2 years ago
AVDL
2 years ago
AXSM
2 years ago
AMRX
2 years ago
CORT
2 years ago
IRWD
2 years ago
SUPN
3 years ago
RVNC
3 years ago
SUPN
3 years ago
HRMY
3 years ago
HZNP
3 years ago
SUPN
4 years ago
AMPH
David Amsellem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Supernus Pharmaceuticals IncSUPN | 11 | Hold | $40.00 | -10.71% | Maintains | 20 days ago |
Amgen IncAMGN | 5 | Strong Buy | $342.00 | +24.49% | Maintains | 24 days ago |
Biogen IncBIIB | 2 | Hold | $118.00 | -18.55% | Maintains | a month ago |
Abbvie IncABBV | 1 | Strong Buy | $231.00 | +4.61% | Assumes | a month ago |
Amphastar Pharmaceuticals IncAMPH | 8 | Hold | $25.00 | -7.34% | Maintains | a month ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $121.00 | +60.95% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 8 | Strong Buy | $175.00 | +22.61% | Maintains | 2 months ago |
Sage Therapeutics IncSAGE | 2 | Hold | $8.50 | -2.07% | Downgrades | 3 months ago |
Organon & CoOGN | 6 | Strong Buy | $18.00 | +72.25% | Maintains | 4 months ago |
Collegium Pharmaceutical IncCOLL | 7 | Hold | $37.00 | +4.11% | Reiterates | 4 months ago |
Jazz Pharmaceuticals PLCJAZZ | 9 | Strong Buy | $147.00 | +13.48% | Reiterates | 4 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $65.00 | +40.85% | Initiates Coverage On | 5 months ago |
Optinose IncOPTN | 3 | Hold | $9.00 | -6.25% | Downgrades | 6 months ago |
Xeris Biopharma Holdings IncXERS | 5 | Hold | $4.00 | -47.85% | Reiterates | 6 months ago |
Indivior PLCINDV | 5 | Strong Buy | $13.00 | -43.40% | Maintains | 6 months ago |
Viatris IncVTRS | 7 | Hold | $10.00 | +3.95% | Reiterates | 6 months ago |
Teva Pharmaceutical Industries LtdTEVA | 7 | Strong Buy | $30.00 | +63.22% | Maintains | 8 months ago |
Intra Cellular Therapies IncITCI | 1 | Hold | $132.00 | +0.10% | Downgrades | 8 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Strong Buy | $13.00 | -16.99% | Maintains | 8 months ago |
Amneal Pharmaceuticals IncAMRX | 4 | Strong Buy | $11.00 | +14.46% | Maintains | 10 months ago |
Alkermes PLCALKS | 7 | Strong Buy | $37.00 | +32.76% | Reiterates | a year ago |
Ani Pharmaceuticals IncANIP | 1 | Strong Buy | $68.00 | -28.69% | Initiates Coverage On | a year ago |
Revance Therapeutics IncRVNC | 7 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Bausch Health Companies IncBHC | 4 | Strong Sell | $3.00 | N/A | Downgrades | a year ago |
Pacira Biosciences IncPCRX | 7 | Strong Buy | $42.00 | N/A | Maintains | a year ago |
Aquestive Therapeutics IncAQST | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Ironwood Pharmaceuticals IncIRWD | 3 | Strong Buy | $21.00 | N/A | Maintains | 2 years ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $113.00 | N/A | Maintains | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $45.00 | N/A | Downgrades | 2 years ago |
Tvardi Therapeutics IncTVRD | 3 | Hold | $12.00 | N/A | Downgrades | 2 years ago |
Harmony Biosciences Holdings IncHRMY | 3 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Strong Sell | $17.00 | N/A | Downgrades | 2 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $285.00 | N/A | Initiates Coverage On | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Strong Buy | $110.00 | N/A | Maintains | 3 years ago |
Antares Pharma IncATRS | 1 | Hold | $5.60 | N/A | Downgrades | 3 years ago |
Endo International PLCENDPQ | 3 | Hold | $3.00 | N/A | Maintains | 4 years ago |
Biodelivery Sciences International IncBDSI | 1 | Hold | $5.60 | N/A | Downgrades | 4 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $8.00 | N/A | Downgrades | 4 years ago |
Evofem Biosciences IncEVFM | 1 | Strong Buy | $165.00 | N/A | Initiates Coverage On | 5 years ago |
Impax Laboratories IncIPXL | 1 | Hold | N/A | N/A | Upgrades | 8 years ago |
Societal Cdmo IncSCTL | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.